Creative Medical Technology Holdings Inc (CELZ)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $4.01M
Last updated: Nov 17, 2026 at 4:10 PM ET
Creative Medical Technology Holdings Inc (CELZ) Statistics
Creative Medical Technology Holdings (CELZ) has a market cap of $4.01M. It kept -248870.63% of revenue as net income over the last 12 months. Its share count is up 194.42% from a year earlier.
Total Valuation
| Market Cap | $4.01M |
|---|---|
| Latest price (Nov 17, 2026) | $0.48 |
Key Dates
The next earnings report is expected on Mar 18, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 18, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 6, 2026 |
| Fiscal Year End | December |
Valuation Ratios
| P/B Ratio | 0.5x |
|---|---|
| P/TBV Ratio | 0.5x |
Price Statistics
The stock is down 84.87% over 52 weeks and trades 40.00% below its 50-day average.
| Beta (1Y) | 1.56 |
|---|---|
| 52-Week Change | -84.87% |
| 1-Month Change | -34.15% |
| 3-Month Change | -57.46% |
| 6-Month Change | -78.24% |
| 5-Year Change | -99.10% |
| 10-Year Change | -100.00% |
| Total Return (1Y) | -84.87% |
| Total Return (3Y CAGR) | -52.67% |
| Total Return (5Y CAGR) | -57.66% |
| Max Drawdown (1Y) | -84.38% |
| Max Drawdown (3Y) | -92.61% |
| Sharpe Ratio (1Y) | -1.45 |
| Correlation with SPY (1Y) | 0.17 |
| 50-Day Average | $0.80 |
| 200-Day Average | $1.49 |
| 52-Week Range | $0.52 to $3.15 |
| RSI (14 Days) | 25.8 |
| Average Volume (20 Days) | 88.97K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 23.66x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 23.66x |
|---|---|
| Quick Ratio | 23.66x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -107.35% over the last 12 months, against a 5-year average of -18.69%.
| Return on Equity (ROE) | -107.35% |
|---|---|
| Return on Assets (ROA) | -102.57% |
| ROE (5Y Average) | -18.69% |
| ROA (5Y Average) | -18.17% |
| ROIC (5Y Average) | -64.58% |
| Asset Turnover | 0.00x |
| Inventory Turnover | 0.02x |
Scores
CELZ has an Altman Z-Score of -9.64, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -9.64 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $3.00K over the last 12 months is down 50.00% from the 12 months before.
| Revenue | $3.00K |
|---|---|
| Revenue Growth (YoY) | -50.00% |
| Gross Profit | $2.01K |
| Operating Income | -$7.69M |
| Pretax Income | -$7.47M |
| Net Income | -$7.47M |
| Reported EPS (TTM) | -$1.99 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 95.47% of the $7.28M in total assets.
| Cash and Equivalents | $6.85M |
|---|---|
| Total Debt | $0 |
| Net Cash | $6.85M |
| Net Cash Per Share | $0.90 |
| Working Capital | $6.64M |
| Shareholder Equity | $6.95M |
| Book Value Per Share | $0.92 |
| Tangible Book Value | $6.62M |
| Tangible Book Per Share | $0.87 |
| Total Assets | $7.28M |
| Total Liabilities | $293.23K |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$6.40M |
|---|---|
| FCF Per Share | -$0.86 |
| Depreciation and Amortization | $85.66K |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -256435.00%.
| Gross Margin | 66.87% |
|---|---|
| Operating Margin | -256435.00% |
| Pretax Margin | -248870.63% |
| Net Margin | -248870.63% |
| Gross Margin (5Y Average) | 59.33% |
Growth
Revenue fell 59.24% a year over 3 years.
| Revenue Growth (3Y CAGR) | -59.24% |
|---|---|
| Revenue Growth (5Y CAGR) | -48.43% |
| Book Value Per Share Growth (2Y CAGR) | -34.92% |
| Tangible Book Per Share Growth (2Y CAGR) | -35.31% |
Dividends and Yields
CELZ does not pay a dividend.
| Buyback Yield | -112.07% |
|---|---|
| Shareholder Yield | -112.07% |
Stock Splits
The last split was a 1-for-10 reverse split on Jun 12, 2023.
| Last Split Date | Jun 12, 2023 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:10 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About CELZ
What is CELZ's market cap?
Creative Medical Technology Holdings has a market cap of $4.01M.
How many shares of CELZ are outstanding?
Creative Medical Technology Holdings has 7.60M shares outstanding. The count is up 194.42% from a year earlier.
Does CELZ pay a dividend?
No. Creative Medical Technology Holdings does not pay a dividend.
How much debt does CELZ have?
Creative Medical Technology Holdings has $0 of total debt and $6.85M of cash and equivalents, a net cash position of $6.85M.
CELZ pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors